nach oben

Erschienen in:

10.06.2024 | Original Article

Effect of the lymphocyte-to-monocyte ratio on the prognosis of patients with obstructive colorectal cancer with a colonic stent: a retrospective multicenter study in Japan

verfasst von: Toshio Shiraishi, Tetsuro Tominaga, Takashi Nonaka, Yuma Takamura, Kaido Oishi, Shintaro Hashimoto, Keisuke Noda, Rika Ono, Makoto Hisanaga, Hiroaki Takeshita, Mitsutoshi Ishii, Syosaburo Oyama, Kazuhide Ishimaru, Masaki Kunizaki, Terumitsu Sawai, Keitaro Matsumoto

Erschienen in: Surgery Today | Ausgabe 1/2025

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The prognostic value of the lymphocyte-to-monocyte (LMR) ratio has been reported for various cancers, including colorectal cancer (CRC). The insertion of colonic stents is considered effective for patients with surgically indicated obstructive CRC, but their LMR can vary depending on factors such as inflammation associated with stent dilation and improvement of obstructive colitis. However, the usefulness of the LMR in patients with obstructive CRC and colonic stents and the optimal timing for its measurement remain unclear. We conducted this study to investigate the relationship between the pre-stent LMR and the mid-term prognosis of patients with obstructive CRC and stents as a bridge to surgery (BTS).

Methods

The subjects of this retrospective multicenter study were 175 patients with pathological stage 2 or 3 CRC. Patients were divided into a low pre-stent LMR group (n = 87) and a high pre-stent LMR group (n = 83).

Results

Only 3-year relapse-free survival differed significantly between the low and high pre-stent LMR groups (39.9% vs. 63.6%, respectively; p = 0.015). The pre-stent LMR represented a prognostic factor for relapse-free survival in multivariate analyses (hazard ratio 2.052, 95% confidence interval 1.242–3.389; p = 0.005), but not for overall survival.

Conclusions

A low pre-stent LMR is a prognostic factor for postoperative recurrence in patients with obstructive CRC and a colonic stent as a BTS.

Bretthauer M, Løberg M, Wieszczy P, Kalager M, Emilsson L, Garborg K, NordICC Study Group, et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med. 2022;387(17):1547–56. https://doi.org/10.1056/NEJMoa2208375.CrossRefPubMed

Suh JW, Oh HK, Lee J, Yang IJ, Ahn HM, Kim DW, Seoul Colorectal Research Group (SECOG), et al. Safety of early surgery after self-expandable metallic stenting for obstructive left-sided colorectal cancer. Surg Endosc. 2023;37(5):3873–83. https://doi.org/10.1007/s00464-023-09891-1.CrossRefPubMed

Kim MH, Kang SI, Lee J, Oh HK, Ahn S, Kim DW, Seoul Colorectal Research Group (SECOG), et al. Oncologic safety of laparoscopic surgery after metallic stent insertion for obstructive left-sided colorectal cancer: a multicenter comparative study. Surg Endosc. 2022;36(1):385–95. https://doi.org/10.1007/s00464-021-08293-5.CrossRefPubMed

Sugiura K, Seo Y, Aoki H, Onishi Y, Nishi Y, Kishida N, et al. Long-term and short-term outcomes of laparoscopic versus open resection following tube decompression for obstructive colorectal cancer: a single-center retrospective study. Surg Today. 2022;52(9):1284–91. https://doi.org/10.1007/s00595-022-02458-y.CrossRefPubMed

Sato K, Imaizumi K, Kasajima H, Kurushima M, Umehara M, Tsuruga Y, et al. Short- and long- term outcomes of a self-expandable metallic stent versus a transanal decompression tube for pathological stage II and III left-sided obstructive colorectal cancer: a retrospective observational study. Surg Today. 2022;52(2):268–77. https://doi.org/10.1007/s00595-021-02341-2.CrossRefPubMed

Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–45. https://doi.org/10.1016/S0140-6736(00)04046-0.CrossRefPubMed

Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–503. https://doi.org/10.1016/S1470-2045(14)70263-3.CrossRefPubMed

Pinato DJ, Shiner RJ, Seckl MJ, Stebbing J, Sharma R, Mauri FA. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer. 2014;110(8):1930–5. https://doi.org/10.1038/bjc.2014.145.CrossRefPubMedPubMedCentral

Toyokawa T, Muguruma K, Yoshii M, Tamura T, Sakurai K, Kubo N, et al. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer. BMC Cancer. 2020;20(1):517. https://doi.org/10.1186/s12885-020-07010-0.CrossRefPubMedPubMedCentral

10.

Huang J, Xu L, Luo Y, He F, Zhang Y, Chen M. The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy. Med Oncol. 2014;31(4):883. https://doi.org/10.1007/s12032-014-0883-x.CrossRefPubMed

11.

Inamoto S, Kawada K, Okamura R, Hida K, Sakai Y. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study. Int J Colorectal Dis. 2019;34(7):1303–15. https://doi.org/10.1007/s00384-019-03316-z.CrossRefPubMed

12.

Lee SC, Huh JW, Lee WY, Yun SH, Kim HC, Cho YB, et al. Prognostic value of serum inflammatory markers in colorectal cancer. Int J Colorectal Dis. 2020;35(7):1211–9. https://doi.org/10.1007/s00384-020-03591-1.CrossRefPubMed

13.

Yasui K, Shida D, Nakamura Y, Ahiko Y, Tsukamoto S, Kanemitsu Y. Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients. Br J Cancer. 2021;124(5):933–41. https://doi.org/10.1038/s41416-020-01189-6.CrossRefPubMed

14.

Thiagarajan S, Tan JW, Zhou S, Tan QX, Hendrikson J, Ng WH, et al. Postoperative inflammatory marker surveillance in colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2021;28(11):6625–35. https://doi.org/10.1245/s10434-020-09544-w.CrossRefPubMedPubMedCentral

15.

Taniai T, Haruki K, Hamura R, Fujiwara Y, Furukawa K, Gocho T, et al. The prognostic significance of C-reactive protein-to-lymphocyte ratio in colorectal liver metastases. J Surg Res. 2021;258:414–21. https://doi.org/10.1016/j.jss.2020.08.059.CrossRefPubMed

16.

Chen XQ, Xue CR, Hou P, Lin BQ, Zhang JR. Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer. World J Gastroenterol. 2019;25(33):4970–84. https://doi.org/10.3748/wjg.v25.i33.4970.CrossRefPubMedPubMedCentral

17.

Sato R, Oikawa M, Kakita T, Okada T, Abe T, Yazawa T, et al. The prognostic value of the prognostic nutritional index and inflammation-based markers in obstructive colorectal cancer. Surg Today. 2020;50(10):1272–81. https://doi.org/10.1007/s00595-020-02007-5.CrossRefPubMed

18.

Frago R, Ramirez E, Millan M, Kreisler E, del Valle E, Biondo S. Current management of acute malignant large bowel obstruction: a systematic review. Am J Surg. 2014;207(1):127–38. https://doi.org/10.1016/j.amjsurg.2013.07.027.CrossRefPubMed

19.

Kawai K, Iida Y, Ishihara S, Yamaguchi H, Nozawa H, Hata K, et al. Intraoperative colonoscopy in patients with colorectal cancer: review of recent developments. Dig Endosc. 2016;28(6):633–40. https://doi.org/10.1111/den.12663.CrossRefPubMed

20.

Yang J, Guo X, Wang M, Ma X, Ye X, Lin P. Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS. Sci Rep. 2017;7(1):17166. https://doi.org/10.1038/s41598-017-17130-6.CrossRefPubMedPubMedCentral

21.

Dou X, Wang RB, Yan HJ, Jiang SM, Meng XJ, Zhu KL, et al. Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases. Asian Pac J Cancer Prev. 2013;14(6):3881–5. https://doi.org/10.7314/APJCP.2013.14.6.3881.CrossRefPubMed

22.

Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol. 2010;5:47. https://doi.org/10.1186/1748-717X-5-47.CrossRefPubMedPubMedCentral

23.

Noh OK, Oh SY, Kim YB, Suh KW. Prognostic significance of lymphocyte counts in colon cancer patients treated with FOLFOX chemotherapy. World J Surg. 2017;41(11):2898–905. https://doi.org/10.1007/s00268-017-4104-6.CrossRefPubMed

24.

Yamamoto T, Kawada K, Obama K. Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients. Int J Mol Sci. 2021;22(15):8002. https://doi.org/10.3390/ijms22158002.CrossRefPubMedPubMedCentral

25.

Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett. 2008;267(2):204–15. https://doi.org/10.1016/j.canlet.2008.03.028.CrossRefPubMed

26.

Patysheva M, Frolova A, Larionova I, Afanas’ev S, Tarasova A, Cherdyntseva N, et al. Monocyte programming by cancer therapy. Front Immunol. 2022;13: 994319. https://doi.org/10.3389/fimmu.2022.994319.CrossRefPubMedPubMedCentral

27.

Larionova I, Cherdyntseva N, Liu T, Patysheva M, Rakina M, Kzhyshkowska J. Interaction of tumor-associated macrophages and cancer chemotherapy. Oncoimmunology. 2019;8(7):1596004. https://doi.org/10.1080/2162402X.2019.1596004.CrossRefPubMedPubMedCentral

28.

Chan JCY, Diakos CI, Chan DLH, Engel A, Pavlakis N, Gill A, et al. A longitudinal investigation of inflammatory markers in colorectal cancer patients perioperatively demonstrates benefit in serial remeasurement. Ann Surg. 2018;267(6):1119–25. https://doi.org/10.1097/SLA.0000000000002251.CrossRefPubMed

29.

Li Y, Jia H, Yu W, Xu Y, Li X, Li Q, et al. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection. Int J Cancer. 2016;139(1):220–31. https://doi.org/10.1002/ijc.30071.CrossRefPubMed

Titel: Effect of the lymphocyte-to-monocyte ratio on the prognosis of patients with obstructive colorectal cancer with a colonic stent: a retrospective multicenter study in Japan
verfasst von: Toshio Shiraishi
Tetsuro Tominaga
Takashi Nonaka
Yuma Takamura
Kaido Oishi
Shintaro Hashimoto
Keisuke Noda
Rika Ono
Makoto Hisanaga
Hiroaki Takeshita
Mitsutoshi Ishii
Syosaburo Oyama
Kazuhide Ishimaru
Masaki Kunizaki
Terumitsu Sawai
Keitaro Matsumoto
Publikationsdatum: 10.06.2024
Verlag: Springer Nature Singapore
Erschienen in: Surgery Today / Ausgabe 1/2025
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI: https://doi.org/10.1007/s00595-024-02875-1

Mac-2 binding protein glycosylation isomer as a novel predictor of early recurrence after resection for hepatocellular carcinoma

Original Article

Is the use of direct oral anticoagulants after non-cardiac thoracic surgery safe for patients?

Original Article

Acknowledgment to reviewers

Acknowledgment

Laparoscopic vs. open surgery for rectal cancer in patients with obesity: short-term outcomes and relapse-free survival across age groups

Original Article

Abdominal aortic calcification volume as a preoperative prognostic predictor for pancreatic cancer

Original Article

Surgical outcomes of video-assisted neck surgery for papillary thyroid carcinoma

Original Article

Neu im Fachgebiet Chirurgie

Nackenschmerzen nach Bandscheibenvorfall: Muskeltraining hilft!

15.01.2025
Nackenschmerzen
Nachrichten

Bei hartnäckigen Schmerzen aufgrund einer zervikalen Radikulopathie schlägt ein Team der Universität Istanbul vor, lokale Steroidinjektionen mit einem speziellen Trainingsprogramm zur Stabilisierung der Nackenmuskulatur zu kombinieren.

US-Team empfiehlt Gastropexie nach Hiatushernien-Op.

14.01.2025
Zwerchfellhernie
Nachrichten

Zur Vermeidung von Rezidiven nach Reparatur einer paraösophagealen Hiatushernie sollte einem US-Team zufolge der Magen bei der Op. routinemäßig an der Bauchwand fixiert werden. Das Ergebnis einer randomisierten Studie scheint dafür zu sprechen.

Mit Lidocain kommt der Darm nicht schneller in Schwung

13.01.2025
Kolektomie
Nachrichten

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

12.01.2025
Elektronische Patientenakte
Nachrichten

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Effect of the lymphocyte-to-monocyte ratio on the prognosis of patients with obstructive colorectal cancer with a colonic stent: a retrospective multicenter study in Japan